Recent Quotes (30 days)

You have no recent quotes
chg | %

Innoviva Inc news

   Watch this stock
Showing stories 1 - 10 of about 90   

Articles published

INVA 13.51 -0.30 (-2.17%)
price chart
GSK and Innoviva Report Positive Headline Results from IMPACT Study Showing ...
LONDON--(BUSINESS WIRE)--GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced positive headline results from the landmark phase III IMPACT study of Trelegy Ellipta, the first and only FDA approved once-daily ...
Glaxo/Innoviva's Triple Combo Therapy Gets FDA Nod for COPD  Nasdaq
GlaxoSmithKline: Results positive in inhaler study  MarketWatch
GSK, Innoviva: Trelegy Ellipta Gets CHMP Positive Opinion In Europe For COPD
( - GlaxoSmithKline Plc (GSK.L, GSK) and Innoviva, Inc. (INVA) announced Friday that Trelegy Ellipta once-daily single inhaler triple therapy received positive opinion from the European Medicines Agency'sCommittee for Medicinal Products for ...
GSK, Innoviva Gain FDA Approval for First Once-Daily Single Inhaler Triple ...
Mike Aguiar, CEO of Innoviva, Inc., added, “This approval represents a significant therapeutic convenience for those appropriate patients already on Breo Ellipta, that require additional bronchodilation or for those patients already on a combination of ...
Theravance Biopharma Highlights Approval of Trelegy Ellipta (Closed Triple ...  Markets Insider
FDA OKs Glaxo's inhaler, first one to combine 3 medicines  ABC News
Innoviva to Participate in Baird Global Healthcare Conference on September 7
BUSINESS WIRE)--Innoviva, Inc. (NASDAQ: INVA) today announced that Michael W. Aguiar, Innoviva's President and Chief Executive Officer and Eric d'Esparbes, the Company's Senior Vice President and Chief Financial Officer will participate in the 2017 ...
Innoviva, Inc. (INVA) and Chegg, Inc. (CHGG) Does It Again With Another ...
Innoviva, Inc. (NASDAQ:INVA) traded at an unexpectedly high on Friday, posting a -1.28% after which it closed the day' session at $13.87.
Study from GlaxoSmithKline and Innoviva Inc. improves asthma control
GlaxoSmithKline plc and Innoviva recently conducted a first of its kind research on asthma control. The Salford Lung Study (SLS) results revealed patients initiated with Relvar Ellipta, a once a day inhaler, had twice the odds of achieving an ...
Breaking: Innoviva Inc (NASDAQ:INVA) Stock Through Resistance -- Technicals ...
Breaking: Innoviva Inc (NASDAQ:INVA) has hit maximum technical strength -- watch the technical oscillators for momentum gaps.
Innoviva, Inc. (NASDAQ:INVA) Rating Lowered to Hold at ValuEngine  The Ledger Gazette
Innoviva, Inc. (NASDAQ:INVA) Sees Heavy Trading Volume with 1797K Shares ...  Modern Readers
Innoviva, Inc. (NASDAQ:INVA) Lowered to Hold at ValuEngine
ValuEngine lowered shares of Innoviva, Inc. (NASDAQ:INVA) from a buy rating to a hold rating in a research note released on Friday, September 1st.
Innoviva, Inc. (NASDAQ:INVA) Trading Down – Shorts Up 15.22%  Modern Readers
Chicago Equity Partners LLC Acquires 196945 Shares of Innoviva, Inc. (INVA)  StockNewsTimes
Innoviva Inc. (INVA) Moves Lower on Volume Spike for September 15
Innoviva Inc. (INVA) traded on unusually high volume on Sep. 15, as the stock lost 1.28% to close at $13.87. On the day, Innoviva Inc. saw 1.86 million shares trade hands on 5,052 trades. Considering that the stock averages only a daily volume of 962 ...
Innoviva, Inc. (NASDAQ:INVA) Traded Over Its 50 Day Moving Average  First News 24
Innoviva, Inc. (INVA) Shares Bought by American Century Companies Inc.  TrueBlueTribune
Can These Stocks Hold the Traction? Gapping up Pre-Bell: Innoviva, Inc ...
Will shares of Innoviva, Inc. (NASDAQ:INVA) hold onto their early gains? The stock is gapping up 4.06% before market open touching $14.30 on a recent bid.
RSI Oversold/Overbought Signals to Track – Innoviva, Inc. (NASDAQ:INVA)  Hot Stocks Point